United States - English - NLM (National Library of Medicine)

chengdu shuode pharmaceutical co., ltd - nalmefene hydrochloride (unii: k7k69qc05x) (nalmefene - unii:tov02tdp9i) - nalmefene hydrochloride injection is indicated for the complete or partial reversal of opioid drug effects, including respiratory depression, induced by either natural or synthetic opioids. nalmefene hydrochloride injection is indicated in the management of known or suspected opioid overdose. nalmefene hydrochloride injection is contraindicated in patients with a known hypersensitivity to the product. nalmefene hydrochloride injection is an opioid antagonist with no agonist activity. it has no demonstrated abuse potential, is not addictive, and is not a controlled substance.

United States - English - NLM (National Library of Medicine)

chengdu rosun disinfection pharmaceutical co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - place enough product on hands to cover all surfaces. rub hands together until dry. disinfection sterilization no rinseing

United States - English - NLM (National Library of Medicine)

chengdu rosun disinfection pharmaceutical co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - place enough product on hands to cover all surfaces. rub hands together until dry. disinfection sterilization no rinseing

United States - English - NLM (National Library of Medicine)

chengdu rosun disinfection pharmaceutical co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - 1.place enough product in your palm to throughly cover your hands. 2.rub hands briskly until dry. 3.children under 6 years of age should be supervised when using this product. disinfection sterilization no rinseing

United States - English - NLM (National Library of Medicine)

chengdu rosun disinfection pharmaceutical co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - 1.place enough product in your palm to throughly cover your hands. 2.rub hands briskly until dry. 3.children under 6 years of age should be supervised when using this product. disinfection sterilization no rinseing

United States - English - NLM (National Library of Medicine)

chengdu rosun disinfection pharmaceutical co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - 1.place enough product in your palm to throughly cover your hands. 2.rub hands briskly until dry. 3.children under 6 years of age should be supervised when using this product. disinfection sterilization no rinseing

United States - English - NLM (National Library of Medicine)

meitheal pharmaceuticals inc. - levoleucovorin calcium (unii: 778xl6vbs8) (levoleucovorin - unii:990s25980y) - levoleucovorin injection is indicated for: - rescue after high-dose methotrexate therapy in adult and pediatric patients with osteosarcoma. - diminishing the toxicity associated with overdosage of folic acid antagonists or impaired methotrexate elimination in adult and pediatric patients. - the treatment of adults with metastatic colorectal cancer in combination with fluorouracil. limitations of use levoleucovorin injection is not indicated for pernicious anemia and megaloblastic anemia secondary to the lack of vitamin b12 , because of the risk of progression of neurologic manifestations despite hematologic remission. levoleucovorin is contraindicated in patients who have had severe hypersensitivity to leucovorin products, folic acid or folinic acid [see adverse reactions (6.2)] . risk summary there are limited data with levoleucovorin use in pregnant women. animal reproduction studies have not been conducted with levoleucovorin. levoleucovorin is administered in combination with methotrexate or fluorouracil, which can cause embryo-fetal harm. refer to methotrexate and fluorouracil prescribing information for additional information. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. risk summary there are no data on the presence of levoleucovorin in human milk or its effects on the breastfed infant or on milk production. levoleucovorin is administered in combination with methotrexate or fluorouracil. refer to methotrexate and fluorouracil prescribing information for additional information. the safety and effectiveness of levoleucovorin have been established in pediatric patients for rescue after high-dose methotrexate therapy in osteosarcoma and diminishing the toxicity associated with overdosage of folic acid antagonists or impaired methotrexate elimination. use of levoleucovorin in pediatric patients is supported by open-label clinical trial data in 16 pediatric patients 6 years of age and older, with additional supporting evidence from literature [see clinical studies (14.1)]. the safety and effectiveness of levoleucovorin have not been established for the treatment of pediatric patients with advanced metastatic colorectal cancer. clinical studies of levoleucovorin in the treatment of osteosarcoma did not include patients aged 65 and over to determine whether they respond differently from younger patients. in the ncctg clinical trial of levoleucovorin in combination with fluorouracil for the treatment of metastatic colorectal cancer, no overall differences in safety or effectiveness were observed between patients age 65 years and older and younger patients.

Singapore - English - HSA (Health Sciences Authority)

hygeian medical supplies (pte) ltd. - tablets

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: philgen pharmaceuticals inc.; distributor: philgen pharmaceuticals inc. - sterile water for injection - sterile water for injection (i.m./i.v./s.c.) - 10ml

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: philgen pharmaceuticals inc.; distributor: philgen pharmaceuticals inc. - ceftazidime (as pentahydrate) - powder for injection (im/iv) - 1 g